chr10-72133059-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001198800.3(ASCC1):āc.869A>Gā(p.Asn290Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00201 in 1,613,978 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001198800.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASCC1 | NM_001198800.3 | c.869A>G | p.Asn290Ser | missense_variant, splice_region_variant | 8/10 | ENST00000672957.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASCC1 | ENST00000672957.1 | c.869A>G | p.Asn290Ser | missense_variant, splice_region_variant | 8/10 | NM_001198800.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00128 AC: 195AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00117 AC: 294AN: 251444Hom.: 1 AF XY: 0.00131 AC XY: 178AN XY: 135894
GnomAD4 exome AF: 0.00209 AC: 3052AN: 1461682Hom.: 3 Cov.: 31 AF XY: 0.00205 AC XY: 1493AN XY: 727146
GnomAD4 genome AF: 0.00128 AC: 195AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.00113 AC XY: 84AN XY: 74488
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 11, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | ASCC1: BP4 - |
Barrett esophagus/esophageal adenocarcinoma Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 27, 2011 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Aug 07, 2018 | - - |
Spinal muscular atrophy with congenital bone fractures 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at